LSC - 2022 - Biomarker identification to assess effects of bone-marrow derived mesenchymal stromal cell-therapy in emphysema through immune profiling
P. Khedoe (Leiden, Netherlands), L. Jia (Leiden, Netherlands), N. Li (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), F. Koning (Leiden, Netherlands), J. Stolk (Leiden, Netherlands)
Source: International Congress 2022 – Cellular involvement in lung diseases
Session: Cellular involvement in lung diseases
Session type: Oral Presentation
Number: 3661
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Khedoe (Leiden, Netherlands), L. Jia (Leiden, Netherlands), N. Li (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), F. Koning (Leiden, Netherlands), J. Stolk (Leiden, Netherlands). LSC - 2022 - Biomarker identification to assess effects of bone-marrow derived mesenchymal stromal cell-therapy in emphysema through immune profiling. 3661
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|